SOD2 and metabolic dysfunction-associated steatotic liver disease: The recipient’s superoxide dismutase-2 (SOD-2) rs4880-A variant and the donor’s HSD17B13 rs6834314 variant have been associated with a reduced risk of NAFLD occurrence [60].